A2ZT34 Stock Overview
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Azenta, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$21.34 |
| 52 Week High | US$29.07 |
| 52 Week Low | US$21.06 |
| Beta | 1.48 |
| 11 Month Change | -5.11% |
| 3 Month Change | -5.11% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -43.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| A2ZT34 | BR Life Sciences | BR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how A2ZT34 performed against the BR Life Sciences industry.
Return vs Market: Insufficient data to determine how A2ZT34 performed against the BR Market.
Price Volatility
| A2ZT34 volatility | |
|---|---|
| A2ZT34 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: A2ZT34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine A2ZT34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 3,300 | John P. Marotta | www.azenta.com |
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions.
Azenta, Inc. Fundamentals Summary
| A2ZT34 fundamental statistics | |
|---|---|
| Market cap | R$12.12b |
| Earnings (TTM) | -R$954.17m |
| Revenue (TTM) | R$3.81b |
3.2x
P/S Ratio-12.7x
P/E RatioIs A2ZT34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2ZT34 income statement (TTM) | |
|---|---|
| Revenue | US$656.32m |
| Cost of Revenue | US$388.99m |
| Gross Profit | US$267.34m |
| Other Expenses | US$431.51m |
| Earnings | -US$164.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.60 |
| Gross Margin | 40.73% |
| Net Profit Margin | -25.01% |
| Debt/Equity Ratio | 0% |
How did A2ZT34 perform over the long term?
See historical performance and comparison